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Abstract
The peptide hormone Urocortin 3 (Ucn 3) is abundantly and exclusively expressed in mouse pancreatic beta cells where it
regulates insulin secretion. Here we demonstrate that Ucn 3 first appears at embryonic day (E) 17.5 and, from approximately
postnatal day (p) 7 and onwards throughout adult life, becomes a unifying and exclusive feature of mouse beta cells. These
observations identify Ucn 3 as a potential beta cell maturation marker. To determine whether Ucn 3 is similarly restricted to
beta cells in humans, we conducted comprehensive immunohistochemistry and gene expression experiments on macaque
and human pancreas and sorted primary human islet cells. This revealed that Ucn 3 is not restricted to the beta cell lineage
in primates, but is also expressed in alpha cells. To substantiate these findings, we analyzed human embryonic stem cell
(hESC)-derived pancreatic endoderm that differentiates into mature endocrine cells upon engraftment in mice. Ucn 3
expression in hESC-derived grafts increased robustly upon differentiation into mature endocrine cells and localized to both
alpha and beta cells. Collectively, these observations confirm that Ucn 3 is expressed in adult beta cells in both mouse and
human and appears late in beta cell differentiation. Expression of Pdx1, Nkx6.1 and PC1/3 in hESC-derived Ucn 3+ beta cells
supports this. However, the expression of Ucn 3 in primary and hESC-derived alpha cells demonstrates that human Ucn 3 is
not exclusive to the beta cell lineage but is a general marker for both the alpha and beta cell lineages. Ucn 3+ hESC-derived
alpha cells do not express Nkx6.1, Pdx1 or PC1/3 in agreement with the presence of a separate population of Ucn 3+ alpha
cells. Our study highlights important species differences in Ucn 3 expression, which have implications for its utility as
a marker to identify mature beta cells in (re)programming strategies.
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Introduction
Urocortin 3 (Ucn 3) is a peptide hormone that belongs to the
corticotropin-releasing factor (CRF) subfamily of peptide hor-
mone, which also includes Ucn 1 and 22 [1,2,3]. Each peptide
activates at least one of two closely related CRF receptors, CRFR1
and CRFR2, which belong the class B family of G protein-coupled
receptors. Ucn 3 is abundantly and exclusively expressed in beta
cells of the mouse pancreas [4] where it is required for full glucose-
and incretin-stimulated insulin secretion [5]. Ucn 3 secretion from
the beta cell is glucose-dependent and involves the ATP-sensitive
potassium (KATP) channel [5]. These islet-autonomous actions of
Ucn 3 suggest the local presence of cognate receptors, which we
confirmed by demonstrating expression of the alpha isoform of the
CRFR2 receptor in MIN6 insulinoma cells and primary rodent
and human islets [6].
Great progress has been made over the last decade in the ability
to promote the differentiation of hESCs towards beta cells. Our
increased understanding of the complex sequence of events that is
required to drive beta cell differentiation culminated in detailed in
vitro differentiation protocols [7,8,9]. While these protocols are
effective in driving the differentiation from hESCs to pancreatic
endoderm and endocrine progenitor cells in vitro, the resulting cells
can only mature into glucose responsive functional beta cells when
implanted into rodent recipients [9,10,11]. By contrast, endocrine
differentiation of hESC-derived pancreatic endoderm in vitro
produces insulin+ cells that co-express multiple endocrine
hormones and fail to secrete insulin in a regulated manner [12].
Therefore, markers for mature functional beta cells that can be
used to screen for compounds promoting beta cell differentiation in
vitro are of considerable interest to the field of diabetes research.
Similarly, strategies that seek to generate beta cells through
transdifferentiation from diverse sources, such as non-beta
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endocrine, acinar, liver, and biliary epithelial cells
[13,14,15,16,17,18] would benefit from a maturation marker to
help distinguish mature glucose-responsive and functional beta
cells from immature insulin+ cells. Here we describe that Ucn 3
marks beta cells in rodents relatively late in development and is
expressed in hESC-derived Pdx1+, Nkx6.1+ and PC1/3+ mature
beta cells after engraftment in vivo. However, we also find that in
primates Ucn 3 expression is not restricted to the beta cell lineage,
but marks alpha cells as well. While these observations identify
Ucn 3 expression as a feature of mature beta cells in rodents, they
suggest that in humans, Ucn 3 is instead a general maturation
marker of alpha and beta cells.
Results
Ucn 3 is expressed in mouse beta cells starting at E17.5
We previously reported that Ucn 3 expression in the adult
murine islet is exclusive to beta cells [4]. Here we confirmed and
extended these findings by demonstrating that Ucn 3 fully
overlapped with insulin in islets of adult wild type mice, but did
not co-localize with glucagon or somatostatin (Fig. 1A, B). Ucn 3
immunoreactivity was abolished in islets of Ucn 3 null littermates,
underscoring the specificity of our antiserum (Fig. 1C, D). Ucn 3
expression was retained in purified mouse primary beta cells
obtained by FACS sorting dissociated islets from MIP-GFP
reporter mice, further confirming the localization of Ucn 3
expression to beta cells (Fig. 1E), while expression of the alpha cell
marker glucagon and the delta cell marker somatostatin is lost.
Note that both insulin and Ucn 3 expression remain present in the
GFP-negative fraction due to the mosaic expression of the GFP
reporter in only approximately half of all beta cells of this
transgenic line, as discussed elsewhere [19,20].
The first appearance of Ucn 3 in embryonic development and
the extent of its overlap with insulin and other endocrine markers
have not been comprehensively analyzed. We examined Ucn 3
expression by immunohistochemistry at different stages of
embryonic development and early post-natal life. We observed
Ucn 3 expression as early as E17.5 in a subset of insulin+ cells
(Fig. 2E, F). No Ucn 3 immunoreactivity was observed at E12.5 or
E15.5 (Fig. 2A–D). At E19.5, as islets are adopting their distinctive
architecture, the number of Ucn 3+ beta cells increased (Fig. 2G,
H) and by p7 the majority of insulin+ cells co-expressed Ucn 3
(Fig. 2I, J). This includes the insulin+ cells that appear in singlets or
small clusters in the acinar tissue, although Ucn 3 staining in these
cells was weaker compared to Ucn 3 expression within islets in the
first week of life (Fig. 2K, K’). From p14 onwards, Ucn 3 and
insulin expression completely overlapped (Fig. 2L–O). We did not
observe co-localization of Ucn 3 with glucagon or somatostatin at
any point during mouse embryonic development or postnatal life.
Ucn 3 expression is a characteristic shared by primate
alpha and beta cells
As species differences between primate and rodent islets are well
documented [21,22,23,24], we next assessed the expression
pattern of Ucn 3 in human pancreas. In agreement with our
previous observations in mouse, Ucn 3 immunoreactivity in
human pancreas co-localized with insulin (Fig. 3A). However,
while Ucn 3 expression in the mouse pancreas is restricted to the
beta cell lineage, a sizeable fraction of Ucn 3+ cells in the human
pancreas did not express insulin, but instead co-expressed
glucagon (Fig. 3B). As the procurement process for human
pancreas can pose a challenge to obtain pristine tissue quality, we
obtained a pancreas specimen from a pig-tailed macaque (Macaca
nemestrina), collected and fixed immediately post-mortem. Immu-
nostaining of serial sections of macaque pancreas confirmed that
Ucn 3 co-localizes with insulin (Fig. 3C) and glucagon (Fig. 3D) in
islets. We also assessed Ucn 3 expression in human donor islets
that were immersion fixed upon arrival. Again Ucn 3 expression in
serial sections of the same islet was evident in the large majority of
alpha and beta cells with no Ucn 3 expression in delta cells
(Fig. 4A–B), findings that were confirmed using a second Ucn 3
antiserum (not shown). Controls stained for Ucn 1 (Fig. 4C, D),
a peptide related to Ucn 3 that is not expressed in islets, or controls
without primary antibody (Fig. 4E, F) did not show any staining,
Figure 1. Ucn 3 expression in adult mouse islets is restricted to
beta cells. Ucn 3 immunoreactivity overlaps completely with insulin
(A) and not glucagon (B). Staining of the pancreas of a Ucn 3 null
littermate demonstrates complete abrogation of Ucn 3 immunoreac-
tivity to confirm the specificity of our antiserum (C, D). Details of panel C
without glucagon (top) or somatostatin (bottom) channel reveals no
Ucn 3 signal in alpha cells (arrows) or delta cells (asterisks). Expression
profiling of dissociated FACS-sorted primary mouse beta cells from MIP-
GFP transgenic mice demonstrates that purified beta cells have lost
glucagon and somatostatin expression and are enriched for insulin and
Ucn 3 expression (E). Note that both insulin and Ucn 3 expression
remain present in the GFP-negative fraction due to the mosaic
expression of the GFP reporter in this transgenic line.
doi:10.1371/journal.pone.0052181.g001
Urocortin3 Marks Mature Human Alpha and Beta Cells
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confirming the specificity of our Ucn 3 antiserum on the human
material. At higher magnification, the colocalization of Ucn 3 with
insulin and glucagon is evident in the large majority of beta and
alpha cells, respectively, although there are occasional insulin+ and
glucagon+ cells that do not co-express Ucn 3 (Fig. 4G, H).
To substantiate our findings with a method independent of the
Ucn 3 antiserum, we conducted gene expression analysis on FACS
sorted dissociated primary human islet cells. We collected FACS-
purified human islet fractions from three individual donors, using
an established method based on validated monoclonal antibodies
against human islet cell surface markers [25]. Quantitative PCR
analysis of these purified islet populations (Fig. 4I) demonstrated
that the human beta cell fraction was enriched for insulin and Ucn
3 and depleted for glucagon expression, as expected (Fig. 4J). The
human alpha cell fraction showed increased glucagon expression
and was depleted for the expression of both insulin and
somatostatin, confirming successful alpha cell enrichment. Ucn 3
expression was enriched along with glucagon in the human alpha
cell population, providing independent confirmation that not only
human beta cells but also alpha cells expressed Ucn 3 (Fig. 4K).
The acinar cell fraction showed robust depletion for all endocrine
markers (Fig. 4L).
Ucn 3 expression is induced during maturation of hESC-
derived alpha and beta cells
A recent study identified Ucn 3 as a beta cell-specific maturation
marker and suggested potential utility to distinguish immature
from mature hESC-derived beta cells [26]. However, our data in
macaque and human pancreas and human donor islets suggest
that Ucn 3 expression in primates is not restricted to the beta cell
Figure 2. Ucn 3 expression trails the appearance of insulin in ontogeny. Ucn 3 expression, undetectable by immunohistochemistry at E12.5
(A, B) and E15.5 (C, D), first appears in a subset of beta cells around E17.5 of embryonic development (E, F). The fraction of Ucn 3+ beta cells increases
perinatally (G, H) and by p7, the majority of beta cells (I, J), including those appearing as singlets in the acinar tissue (K) are clearly Ucn 3+. From p14
onwards, Ucn 3 expression is evident in all beta cells (L–O).
doi:10.1371/journal.pone.0052181.g002
Urocortin3 Marks Mature Human Alpha and Beta Cells
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lineage. Therefore, we evaluated Ucn 3 expression in hESCs in
comparison to key intermediate differentiation stages towards the
formation of hESC-derived mature endocrine cells. Expression
profiles obtained by qRT-PCR revealed little expression of Ucn 3
mRNA in embryonic stem cells or definitive endoderm cultures.
CD142-enriched pancreatic endoderm cells did not express Ucn 3,
while CD200-enriched polyhormonal cells derived from the same
pancreatic cultures [11] started to express Ucn 3. High expression
of Ucn 3 was detected in grafts 140 days following implantation in
vivo (Fig. 5A). These findings demonstrated robust induction of
Ucn 3 following engraftment and maturation of hESC-derived
pancreatic endoderm in vivo, but did not identify the cellular source
of its expression. Therefore, we assessed Ucn 3 expression by
immunohistochemistry following engraftment of hESC-derived
pancreatic endoderm in recipient mice. Prior to transplant the
hESC-derived pancreatic endoderm contained a minor fraction of
insulin+ and glucagon+ cells, which are mostly polyhormonal cells
that do not contribute to the formation of mature beta cells [11].
Ucn 3 was undetectable in the majority of these hormone+ cells
(Fig. 5B, C), although faint Ucn 3 immunoreactivity was
occasionally observed in glucagon+ cells (Fig. 5C, inset), in line
with the start of Ucn 3 expression in polyhormonal cells by qRT-
PCR (Fig. 5A). In close agreement to our qRT-PCR findings, Ucn
3 expression markedly increased to label 79% of beta cells and
68% of alpha cells (107 out of 136 beta cells and 102 out of 150
alpha cells, counted across 7 random fields of view) following
grafting in the epidydimal fat pad of recipient mice for 128 days
(Fig. 5D). Similar findings were obtained in grafts transplanted
subcutaneously in a TheraCyte encapsulation device for 140 days
(38%, or 331 out of 862 insulin+ cells and 45%, or 126 out of 278
glucagon+ cells counted across 18 random fields of view) (Fig. 5E–
F). Only a small fraction of cells (,4% or 19 out of 476 Ucn 3+
cells) appeared to express Ucn 3 but not insulin or glucagon (not
shown). The origins and significance of this small Ucn 3+
population that does not co-express insulin or glucagon is currently
not known. Nevertheless, the large majority of Ucn 3+ cells
expressed insulin (Fig. 5G) or glucagon (Fig. 5H), in agreement
with our earlier findings demonstrating that Ucn 3 marked alpha
as well as beta cells in human and macaque pancreas and sorted
human islet cells.
The observation that Ucn 3 expression in grafts of hESC-
derived pancreatic endoderm at the time of graft collection is
restricted to a subset of beta cells is reminiscent of our findings
during development, where Ucn 3 is not expressed in the majority
of beta cells until p7 (Fig. 2) and indicates that Ucn 3 marks a more
mature subset of beta cells, as has been previously suggested [26].
To substantiate, we co-labeled grafts of hESC-derived pancreatic
endoderm following transplantation in vivo for Ucn 3, insulin and
glucagon as well as Pdx1 and Nkx6.1. These experiments
demonstrate that Ucn 3+ cells that co-express insulin, also express
Pdx1 (Fig. 6A, B) or Nkx6.1 (Fig. 6C, D). This supports the
identity of Ucn 3 as a maturity marker whose expression in the
beta cell lineage follows that of Pdx1, Nkx6.1 and insulin. In
contrast, Ucn 3 expression in alpha cells, identified by co-labeling
with glucagon, does not overlap with Pdx1 (E, F) or Nkx6.1 (G, H),
whose expression is lost from mature alpha cells.
While continued expression of Pdx1 and Nkx6.1 in beta cells is
required for the transcriptional program that maintains beta cell
identity [27,28], they do not directly participate in the processing
and secretion of insulin. Therefore, we colocalized Ucn 3 with
PC1/3, which is a prohormone convertase required for pro-insulin
to insulin processing [29]. In human islets, PC1/3 expression
overlaps with the expression of Ucn 3 in insulin+ beta cells
(Fig. 7A), but does not label Ucn 3+ alpha cells (Fig. 7B), in line
with published work that demonstrates that PC1/3 is expressed in
human beta but not alpha cells [30]. Staining of grafts of hESC-
derived pancreatic endoderm reveals that Ucn 3+ beta cells co-
express PC1/3 (Fig. 8A, B). A fraction of PC1/3+ beta cells does
not yet express Ucn 3, which places the appearance of Ucn 3 after
that of PC1/3 in the development of hESC-derived beta cells and
correlates the onset of Ucn 3 expression with functional maturity.
In line with our observations in human islets, Ucn 3 expression in
hESC-derived alpha cells does not overlap with PC1/3 expression
(Fig. 8C, D).
Ucn 3 is a maturation marker for human alpha cells
Our observation that Ucn 3 colocalized with glucagon after
implantation of hESC-derived pancreatic cultures into mice raised
the possibility that Ucn 3 constitutes a maturation marker for
human alpha cells in addition to human beta cells. Therefore, we
assessed Ucn 3 expression in grafts of hESC-derived polyhormonal
cells that differentiate predominantly into glucagon+ mature alpha
cells upon implantation in vivo [11,31]. Polyhormonal cells were
purified from hESC-derived pancreatic cultures, which do not
express Ucn 3 (Fig. 5A–C), on the basis of CD318 expression and
grafted in the epidydimal fat pads of mice [11]. Control mice were
grafted with CD142-enriched pancreatic endoderm cells or with
non-enriched pancreatic cultures [11]. Both non-enriched (Fig. 9A)
and CD142-enriched control grafts (Fig. 9B) gave rise to a mixed
population of alpha and beta cells, both of which co-express Ucn 3
as previously observed (Fig. 5). In contrast, CD318-enriched cells
differentiated predominantly into glucagon+ alpha cells (Fig. 9C) in
the absence of significant insulin expression (not shown, see [11]).
At nine weeks following implantation, these alpha cells had
acquired Ucn 3 expression. These findings further support the
notion that the acquisition of Ucn 3 expression coincides with
alpha cell maturation whether derived by the transition of
Figure 3. Ucn 3 expression in the primate pancreas is a feature
of alpha and beta cells. Ucn 3 immunoreactivity co-localizes with
insulin as well as glucagon in both human (A, B) and macaque (C, D)
pancreas.
doi:10.1371/journal.pone.0052181.g003
Urocortin3 Marks Mature Human Alpha and Beta Cells
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polyhormonal endocrine precursor cells to glucagon single+ cells or
by the differentiation of alpha cells from pancreatic progenitors
after engraftment in mice.
Discussion
Ucn 3 was co-discovered by our group a decade ago as the
fourth member of the corticotropin-releasing factor family of
peptide hormones [32,33]. We subsequently reported that Ucn 3 is
abundantly and exclusively expressed in beta cells of the mouse
islet and is required for full glucose- and incretin-stimulated insulin
secretion [4,5]. The great and unmet need for a source of
abundant and functional beta cells for a cell-based therapy of type
1 diabetes has initiated many efforts to differentiate beta cells from
hESCs or induced pluripotent stem cells (iPSCs). From these
studies it has become apparent that insulin expression alone is
insufficient to define mature functional beta cells [11,34,35,36]. A
recent study reported the onset of Ucn 3 expression in mouse
Figure 4. Ucn 3 is expressed in alpha and beta cells in freshly fixed human islets. Serial sections of the same human islet demonstrate that
Ucn 3 expression co-localizes with insulin (A) and glucagon (B), but not somatostatin. The same islet shows no immunoreactivity for the related
peptide Ucn 1 using an antiserum similar to the one used for the detection of Ucn 3 (C, D). Additional controls stained with secondary antibody only
are negative as well (E, F). High power magnifications illustrate that the large majority of beta (G) and alpha (H) cells co-express Ucn 3 (arrows),
although occasional insulin+ and glucagon+ cells can be found that do not stain for Ucn 3 (asterisks in G and H). Ucn 3 gene expression in FACS-
purified dissociated human islet cells (I) from three individual donors confirmed that Ucn 3 is enriched in human beta (J) and alpha cells (K). The acinar
cell fraction was depleted for the expression of all endocrine markers (L). Gene expression is normalized to HPRT and expressed relative to pre-sort
levels. Error bars indicate standard errors, asterisks reflect significant differences at a p-value ,0.05 as determined by t-test.
doi:10.1371/journal.pone.0052181.g004
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Figure 5. Expression of Ucn 3 in hESC-cell derived alpha and beta cells requires in vivo maturation. Quantitative PCR analysis of key
differentiation stages towards the human beta cell lineage reveals no Ucn 3 expression at the embryonic stem cell (ES) or definitive endoderm (DE)
stage. While pancreatic cultures enriched for pancreatic endoderm cells (PE) by CD142 did not express Ucn 3, polyhormonal cells (PH) enriched from
the same cultures by CD200, started to express Ucn 3. Implants of hESC-derived pancreatic progenitors robustly express Ucn 3 after differentiation
and maturation in vivo at 140 days post-transplant (Tx). Ucn 3 expression is measured by qRT-PCR, normalized to TATA-box binding protein (TBP) and
plotted relative to ES cells (A). These observations are confirmed on in vitro differentiated hESC-derived pancreatic endoderm, which contains a minor
fraction of polyhormonal cells that express insulin (B) and glucagon (C), but are mostly devoid of Ucn 3 immunoreactivity with the exception of faint
Ucn 3 expression in the occasional glucagon+ cell (C, inset). Ucn 3 immunoreactivity is robustly upregulated 18 weeks following engraftment in the
epidydimal fat pads of mice and demonstrates significant Ucn 3 colocalization with insulin+ beta cells and glucagon+ alpha cells (D). Ucn 3
immunoreactivity is robustly upregulated 140 days post implantation in TheraCyte encapsulation devices and co-localizes with both insulin (E) and
glucagon (F). Heterogeneity exists among both alpha and beta cells regarding the expression of Ucn 3. Arrows indicate Ucn 3+ cells that co-express
insulin (G) or glucagon (H).
doi:10.1371/journal.pone.0052181.g005
Urocortin3 Marks Mature Human Alpha and Beta Cells
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Figure 6. Ucn 3 expression co-localizes with Pdx1 and Nkx6.1 in beta cells but not in alpha cells. Ucn 3 in beta cells differentiated in
implants of hESC-derived pancreatic endoderm cells co-labels with Pdx1 (A, B) or Nkx6.1 (C, D). Ucn 3 in glucagon+ alpha cells does not co-localize
with Pdx1 (E, F) or Nkx6.1 (G, H). Arrows in all panels indicate Ucn 3+ alpha cells, whereas asterisks denote Ucn 3+ mature beta cells. Boxed areas in the
first row of images are magnified in subsequent panels.
doi:10.1371/journal.pone.0052181.g006
Urocortin3 Marks Mature Human Alpha and Beta Cells
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development by immunofluorescence at p6 and suggested that
Ucn 3 has utility as a specific maturation marker for hESC-derived
beta cells [26]. Our observations indicate that Ucn 3 expression is
detectable by immunofluorescence starting at E17.5, over a week
earlier than previously reported [26], and is detected in the
majority of beta cells by p7. These observations place the onset of
Ucn 3 expression past that of insulin to coincide with the early
neonatal window that is implicated in the acquisition of functional
characteristics of mature beta cells including biphasic glucose-
stimulated insulin secretion [37,38,39]. Recent findings from the
Melton group suggest that early neonatal islets do demonstrate
biphasic insulin secretion but at a markedly lower glucose
threshold that shifts to a more mature glucose threshold by p15
[26]. Our observations that Ucn 3 is not expressed in in vitro
generated hESC-derived insulin+ cells, but is exclusively induced
during differentiation and maturation into Pdx1+ or Nkx6.1+ beta
cells following engraftment, further support the notion that Ucn 3
is a late differentiation marker of insulin+ cells in both mice and
humans.
Importantly, our observations contrast the findings reported by
the Melton group [26], in particular with regards to the
distribution of Ucn 3 expression in the human islet. The Melton
study reported Ucn 3 expression in human pancreas to be largely
restricted to beta cells and absent from alpha cells, and to be
upregulated in hESC-derived beta cells following the grafting of
hESC-derived progenitors under the kidney capsule of recipient
mice [26]. Based on a comprehensive set of experiments that
includes immunohistochemistry of human and macaque pancreas
and freshly fixed human islets, as well as parallel gene expression
profiles of FACS-purified dissociated human islet cells, we
conclude that Ucn 3 expression in primates is not restricted to
beta cells but extends to alpha cells. The significance of these
findings is apparent when assessing the appearance of Ucn 3
expression in hESC-derived mature endocrine cells. In both the
human alpha and beta cell lineages, Ucn 3 expression is acquired
late in differentiation, following the implantation step currently
required for functional maturation [9,10,31]. Furthermore, as
demonstrated here, Ucn 3 expression in the human beta cell
lineage is restricted to mature beta cells that retain expression of
Pdx1 and Nkx6.1 and have acquired the PC1/3 expression
required to process pro-insulin to insulin. In contrast, Ucn 3
expression in human alpha cells is associated with a notable
absence of Pdx1, Nkx6.1 and PC1/3 expression as these factors
are absent from mature alpha cells. Moreover, hESC-derived
polyhormonal cells that develop primarily into alpha cells in the
absence of significant beta cell formation [11,31], acquire Ucn 3
expression only upon engraftment into the epidydimal fat pad.
Collectively, these observations suggest that Ucn 3 in humans is
a maturation marker for both the alpha and the beta cell lineages
and warrants a more nuanced approach to Ucn 3 and its utility as
a marker of beta cell maturation, by assessing insulin and glucagon
expression in parallel.
Current protocols for the differentiation of beta cells from
hESCs are successful in generating differentiation-competent
pancreatic endoderm in vitro [7,9,10,11], but the final differenti-
ation steps towards the generation of functional mature beta cells
require exposure of these pancreatic endoderm precursors to
unknown signals associated with in vivo implantation. In light of
our observations, induction of Ucn 3 during this differentiation
and maturation process cannot necessarily be interpreted as a sign
of beta cell maturation, as it could reflect maturation along the
alpha cell lineage as well. Notably, following engraftment of
hESC-derived Pdx1+/Nkx6.1+ pancreatic progenitors Blum et al.
observed Ucn 3 induction in substantially more cells than those
that acquired insulin expression [26]. As Pdx1+/Nkx6.1+ cells
have been demonstrated to differentiate into alpha cells (and lose
Pdx1 and Nkx6.1 expression in the process) as well as beta cells
following engraftment in vivo [10,11], it is possible that some of
these Ucn 3+ insulin- negative cells are in fact hESC-derived Ucn
3+ alpha cells. Similar caution is warranted if Ucn 3 were to be
used as a marker for alpha to beta cell transdifferentiation,
a process described by several recent studies [16,40,41]. While
Ucn 3 expression constitutes a potentially useful marker for the
acquisition of mature beta cell identity by alpha cells in mouse, the
expression of Ucn 3 by human alpha cells precludes its use as
a marker for alpha to beta cell transdifferentiation in humans.
Figure 7. Ucn 3 expression in freshly fixed human islets co-localizes with PC1/3 in beta cells but not in alpha cells. Ucn 3 expression in
human insulin+ beta cells coincides with PC1/3 (A), while Ucn 3+ glucagon+ alpha cells do not express PC1/3 (B). Arrows in all panels indicate Ucn 3+
alpha cells, whereas asterisks denote Ucn 3+ mature beta cells.
doi:10.1371/journal.pone.0052181.g007
Urocortin3 Marks Mature Human Alpha and Beta Cells
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In summary, we described here that the expression of Ucn 3, an
exclusive beta cell marker in mice [4], is less restricted in primates
as it is expressed in primary and hESC-derived human alpha and
beta cells. This suggests that human Ucn 3 expression constitutes
a general endocrine maturation mark and highlights a potential
caveat in the use of Ucn 3 as a maturation marker for hESC-
derived beta cells. Nevertheless, we propose that Ucn 3 remains
useful to assess hESC-derived beta cell maturation, provided that
expression of insulin and glucagon are examined simultaneously to
distinguish Ucn 3+ mature beta from alpha cells.
Materials and Methods
Ethics Statement
Human islets were obtained via the NIDDK-supported In-
tegrated Islet Distribution Program. The Salk Institute for
Biological Studies Institutional Review Board declared the human
islet material used in this study exempt from IRB review under 45
CFR 46.101 (b) Category (4) on April 16, 2008. All animal
experiments were reviewed and approved by Salk Institute Animal
Care and Use Committee (IACUC) and performed in compliance
with the Animal Welfare Act and the ILAR Guide to the Care and
Use of Laboratory Animals. Nonhuman primate samples were
obtained from the tissue bank of the Pathology Services of the Salk
Institute Animal Resources Department. Tissues were collected as
part of other approved experimental studies or during routine
diagnostic necropsies. Primates on approved studies were housed,
fed and handled according to contemporary standards under the
supervision of qualified laboratory animal veterinarians. Every
effort was made to alleviate animal discomfort and pain by
appropriate and routine use of anesthetic and/or analgesic agents.
Biological materials
Pancreata or fresh human islets were immersion fixed in 4%
paraformaldehyde in potassium phosphate-buffered saline (KPBS)
for 3–6 h at 4uC, followed by cryoprotection in 30% sucrose in
KPBS overnight. Pancreata were embedded in Tissue-Tek
(Sakura Finetek USA, Inc.), frozen on dry ice, and sectioned in
14-mm sections for pancreas and 10-mm sections for human islets
on a cryostat and stored at 220uC until use. CyT49 hESCs were
maintained and differentiated as described previously [9]. Tissue
sections of hESC-derived pancreatic cultures engrafted in the
epidydimal fat pads were obtained from ViaCyte and are
described in detail elsewhere [9,11]. Grafts of hESC-derived
pancreatic cultures delivered in a TheraCyte macroencapsulation
device were provided by ViaCyte (Xie et al., 2012, unpublished
data). The diffusion properties of TheraCyte devices have been
studied [42]. Briefly, a device loaded with 36106 cells was inserted
subcutaneously into a SCID-Beige mouse under anesthesia. Grafts
were harvested at 20 weeks after implantation and subjected to
qRT-PCR and Immunohistochemistry analysis.
Immunohistochemistry
After thawing, slides were washed three times for 5 min in
KPBS followed by an overnight incubation at 4uC with primary
antibody in KPBS containing 2% normal donkey serum and 0.4%
Triton. Slides were washed three times for 5 min in KPBS,
incubated for 45 min with secondary antibody and DAPI at 1 mg/
ml, followed by three more 5-min washings in KPBS before
embedding in Prolong Gold Antifade (Life Technologies). Primary
antibodies were guinea pig anti-insulin (Millipore) at 1:500, mouse
anti-insulin (Sigma) at 1:1000, guinea pig anti-glucagon (Millipore)
at 1:7,000 or Goat anti-glucagon (Santa Cruz) at 1:50, sheep anti-
somatostatin (American Research Products Inc.) at 1:1,000, mouse
Figure 8. Ucn 3 expression in hESC-derived beta cells co-
localizes with PC1/3. Ucn 3 in beta cells differentiated in implants of
hESC-derived pancreatic endoderm cells co-labels with PC1/3 (A, B),
while Ucn 3 in glucagon+ alpha cells does not (C, D). Arrows in all panels
indicate Ucn 3+ alpha cells, whereas asterisks denote Ucn 3+ mature
beta cells. Pound signs indicate insulin+, PC1/3+ Ucn 3- immature beta
cells. Boxed areas in the first row of images are magnified in subsequent
panels.
doi:10.1371/journal.pone.0052181.g008
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anti-Nkx6.1 (BCBC) at 1:300, mouse anti-PC1/3 (Novus Biolo-
gicals) at 1:50 and guinea pig anti-Pdx1 (generous gift of Dr. Chris
Wright) at 1:1000. Rabbit anti-human Ucn 3 (#6570; 1:1,000)
and rabbit anti-rat Ucn 1 (#5779; 1:1,000) were generated in
house. Secondary antibodies were Alexa Fluor 488-conjugated
donkey anti-rabbit or donkey anti-goat (Molecular Probes), Alexa
Fluor 488-conjugated goat anti-mouse IgG F(ab’)2, Cy3-conjugat-
ed donkey anti-guinea pig, Dylight 549-conjugated donkey anti-
rabbit, DyLight 649-conjugated donkey anti-sheep or donkey anti-
guinea pig, Cy5-conjugated donkey anti-goat (all Jackson Im-
munoResearch Laboratories Inc., West Grove, PA), at 1:600.
Mouse primary antibodies were used in conjunction with the
MOM blocking kit (Vector Labs) per the manufacturer’s
instructions. Staining for Nkx6.1 required antigen retrieval in
10 mM sodium citrate by microwave. Slides were imaged using
Zeiss LSM710 or 780 confocal microscopes (Zeiss) at the Waitt
Advanced Biophotonics Center Core Facility of the Salk Institute
for Biological Sciences.
FACS sorting
Human islets (20,000 IEQs) were dissociated in 0.25% trypsin-
EDTA solution (Life Technologies) for 5 min at 37uC aided by
gentle mechanical dissociation by pipetting. Cell surface labeling
was carried out according to [25]. In brief, dissociated primary
islet cells were washed in CMRL with 2% FBS, passed through
a 40 micron cell strainer and resuspended at 56106 cells/ml. Cells
were incubated with HIC1-2B4 and HIC3-2D12 mouse hybrid-
oma supernatant at 1:50 for 30 minutes on ice, washed in CMRL
(serum-free) followed by incubation with Alexa Fluor 488-
conjugated goat anti-mouse IgG F(ab’)2 or phycoerythrin-conju-
gated goat anti-mouse IgM F(ab’)2 secondary antibodies re-
spectively (both 1:200 in serum-free CMRL; Jackson ImmunoR-
esearch Laboratories Inc., West Grove, PA). Cells were sorted on
a FACS Aria with an added 561 nm laser line (Becton-Dickinson,
Franklin Lakes, NJ) and 20,000 to 100,000 cells were collected in
Trizol for each population for gene expression analysis. Dissoci-
ated mouse islets from MIP-GFP transgenic animals were sorted as
previously described [20]. Sorting of hESC-derived pancreatic
cultures with CD200 to isolate polyhormonal endocrine cells and
with CD142 to isolate pancreatic endoderm cells was performed as
previously described [11].
Gene expression
RNA was isolated by adding 200 ml chloroform per ml of
Trizol, followed by vigorous mixing and 15 min, 12,000 rcf spin at
4uC. The aqueous phase was transferred to a fresh tube and mixed
Figure 9. Ucn 3 expression is acquired upon implantation of polyhormonal cells that differentiate primarily into alpha cells.
Implantation of hESC-derived pancreatic cultures, either non-enriched (A) or enriched for pancreatic endoderm by CD142 (B) in the epidydimal fat
pad for 9 weeks supports the formation of alpha and beta cells that co-express Ucn 3. In contrast, implantation of CD318-enriched polyhormonal cells
leads to the formation of predominantly alpha cells that co-express Ucn 3, with no detectable expression of insulin (C).
doi:10.1371/journal.pone.0052181.g009
Table 1. Primer information.
gene Primer sequence 59 ) 39 expected amplicon
HPRT qhHPRT.fwu1 GACCAGTCAACAGGGGACAT 95 bp
qhHPRT.rvu1 GTGTCAATTATATCTTCCACAATCAAG
TATA-box qTBP.fw1 TGTGCACAGGAGCCAAGAGT 51 bp
binding protein qTBP.rv1 ATTTTCTTGCTGCCAGTCTGG
insulin qhINS.fw1 GCAGCCTTTGTGAACCAACA 71 bp
qhINS.rv1 CGTTCCCCGCACACTAGGTA
glucagon qhGCG.fw1 GCTGCCAAGGAATTCATTGC 94 bp
qhGCG.rv1 GTCTGCGGCCAAGTTCTTCA
somatostatin qhSST.fw1 CTGTGTCACCGGCGCTC 123 bp
qhSST.rv1 TTGGGTTCAGACAGCAGCTCT
Ucn 3 qhUcn3.fw1 GAGGGAAGTCCACTCTCGGG 137 bp
qhUcn3.rv1 TGTTGAGGCAGCTGAAGATGG
doi:10.1371/journal.pone.0052181.t001
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with 500 ml isopropanol per ml of Trizol prior to application on an
RNeasy micro spin column (Qiagen). After spinning the sample
through, the column was washed with 350 ml wash buffer RW1,
prior to on column DNAse treatment per the manufacturers
instructions. The column was washed with 350 ml of wash buffer
PE and spun extensively to avoid any carry over of ethanol, prior
to elution of RNA in 30 ml of RNAse-free water. Reverse
transcription was conducted with the cDNA archive kit (Applied
Biosystems) and gene expression was assessed by qRT-PCR using
SYBR chemistry on a Lightcycler 480 platform (Roche Diag-
nostics) with primers listed in Table 1.
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